ADRs end higher; BioNTech and Veolia among companies active in the trade

By Kimberly Chin


International stocks traded in New York City closed higher on Monday. The S & P / BNY Mellon US Certificates of Deposit Index rose 0.1% to 163.17. The European index improved 0.1% to 148.50. The Asian index rose 0.3% to 212.75. And the emerging markets index rose 0.4% to 346.12. However, the Latin American index fell 0.8% to 179.18.

BioNTech SE’s ADRs rose 8.6% on Monday after the company announced it had entered into a multi-target discovery collaboration with Crescendo Biologics Ltd. to develop new immunotherapies to treat patients with cancer and other diseases. The initial collaboration will last for three years, the companies said.

The ADRs of Veolia Environnement SA, which are traded over-the-counter, fell 3% on Monday after the company announced it was separating the functions of chief executive and chairman in a radical overhaul of governance, while Estelle Brachlianoff is preparing to succeed Antoine Frerot as CEO.

Takeda Pharmaceutical Co.’s ADRs rose 2.4% after the company said it exercised its option to acquire UK-based Adaptate Biotherapeutics, which focuses on developing antibody-based therapies for the modulation of some T. Takeda cells will acquire the Adaptate antibody base The T cell engagement platform, which includes its preclinical candidate and discovery pipeline programs, he said.


Write to Kimberly Chin at [email protected]

Comments are closed.